NCT03372993View on ClinicalTrials.gov

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 13, 2016

Primary Completion Date

March 31, 2021

Study Completion Date

April 15, 2021

Conditions
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII DeficiencyGlanzmann's Thrombasthenia
Trial Locations (2)

Unknown

Iranian Blood Transfusion Organization (IBTO), Tehran

MAHTA (Iranian Hemophilia and Thrombophilia Association), Tehran

Sponsors
All Listed Sponsors
lead

AryoGen Pharmed Co.

INDUSTRY